Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005
| Tracking Information | |
|---|---|
| First Received Date ICMJE | August 5, 2010 |
| Last Updated Date | August 5, 2010 |
| Start Date ICMJE | Not Provided |
| Primary Completion Date | Not Provided |
| Current Primary Outcome Measures ICMJE |
Absolute incidence of thromboembolic event |
| Original Primary Outcome Measures ICMJE | Same as current |
| Change History | No Changes Posted |
| Current Secondary Outcome Measures ICMJE | Not Provided |
| Original Secondary Outcome Measures ICMJE | Not Provided |
| Current Other Outcome Measures ICMJE | Not Provided |
| Original Other Outcome Measures ICMJE | Not Provided |
| Descriptive Information | |
| Brief Title ICMJE | Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005 |
| Official Title ICMJE | Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005 |
| Brief Summary | The purpose of this study is to describe the incidence of thromboembolic events in relation to pregnancy and when in pregnancy and the puerperal period. |
| Detailed Description | Venous thromboembolism (VTE) still causes maternal death in the western world. The purpose of this study is to estimate the relative and absolute risk of VTE at different gestational ages in pregnant women compared to non-pregnant women. All Danish Women 15 to 49 years old in the period January 1995 through December 2005, free of previous VTE and current use of oral contraceptives are included.Non-pregnant women are controls. |
| Study Type ICMJE | Observational |
| Study Design ICMJE | Observational Model: Cohort Time Perspective: Retrospective |
| Target Follow-Up Duration | Not Provided |
| Biospecimen | Not Provided |
| Sampling Method | Non-Probability Sample |
| Study Population | Danish Women 15 to 49 years old in the period January 1995 through December 2005, free of previous VTE and current use of oral contraceptives. |
| Condition ICMJE | Venous Thromboembolism |
| Intervention ICMJE | Not Provided |
| Study Group/Cohort (s) | Danish Women 15 to 49 years old.
Free of previous VTE and current use of oral contraceptives. |
| Publications * | Not Provided |
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Completed |
| Enrollment ICMJE | Not Provided |
| Completion Date | Not Provided |
| Primary Completion Date | Not Provided |
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
| Gender | Female |
| Ages | 15 Years to 50 Years |
| Accepts Healthy Volunteers | Yes |
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects |
| Location Countries ICMJE | Not Provided |
| Administrative Information | |
| NCT Number ICMJE | NCT01176305 |
| Other Study ID Numbers ICMJE | RAV1 |
| Has Data Monitoring Committee | Yes |
| Responsible Party | Thomas Bergholt, Hillerod Hospital, Gynecolocical-Obstetrical department |
| Study Sponsor ICMJE | Hillerod Hospital, Denmark |
| Collaborators ICMJE | Not Provided |
| Investigators ICMJE | Not Provided |
| Information Provided By | Hillerod Hospital, Denmark |
| Verification Date | October 2009 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|